NEJM Journal Watch/X
Sep 12, 2025, 13:10
NEJM Journal Watch: Should Immunosuppression Be Interrupted During Infection? New Trial Says No Benefit
NEJM Journal Watch posted on X:
”Should Immunosuppression Be Interrupted During an Infection?
In a randomized trial, withholding immunosuppression in patients with auto-inflammatory diseases did not lower the likelihood of progression to serious infection.”
Read more here.
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 15:51Wolfram Ruf: Become a Member of the ISTH Today
-
Aug 23, 2026, 15:47Abdullah Mohsin: Open-Source DVT Diagnostic Framework Launches on GitHub
-
Aug 23, 2026, 15:44Cynthia Alejandra Pastor Alvarez: aPTT or Anti-Xa to Monitor Unfractionated Heparin?
-
Aug 23, 2026, 15:37Nabil Tabish: TEG Reveals the True Effect of Heparin During ECMO
-
Aug 23, 2026, 15:34Ahmed Alotaibi: Could Spray-Dried Plasma Redefine Transfusion Medicine?
-
Aug 23, 2026, 15:23Katerina Pavenski: What’s New in the 2025 AABB and ICTMG Guidelines?
-
Aug 23, 2026, 15:14Denis Nikolov: A Call for Routine UACR Assessment in High-Risk Cardiovascular Patients
-
Aug 23, 2026, 15:1310 Posts Not to Miss This Week
-
Aug 23, 2026, 14:52Alejandro González Veliz: How Plaque Morphology Shapes PCI Outcomes